Skip to main content

AlloVir Inc. Common Stock (ALVR)

About The Company

ALVR Stock Market Logo

AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm’s pipeline includes ALVR106, ALVR109, ALVR108, and others. The company’s product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6.

IPO Year Sector Industry
2020 Health Care Biotechnology: Pharmaceutical Preparations

AlloVir Inc. (ALVR) Latest News

Company Contact & Address (ALVR)

Corporate Headquarters Phone Website
1100 WINTER STREET SUITE 500,
WALTHAM,
Massachusetts,
2451,
United States
+1 617 433-2605 Official ALVR Website

ALVR Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ ALVR

Jobs & Employment at AlloVir Inc.

LinkedIn Company Page https://www.linkedin.com/company/allovir
Official Career & Employment Page Jobs & Careers at AlloVir Inc. (ALVR)

Related & Similar Stock Symbols

GTE Stock Market Price & News

GTE

Gran Tierra Energy Inc. Common Stock

UVE Stock Market Price & News

UVE

UNIVERSAL INSURANCE HOLDINGS INC Common Stock

AZRE Stock Market Price & News

AZRE

Azure Power Global Limited Equity Shares